Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and Moderna.
That puts the shot, which targets XBB.1.5, on track to roll out weeks after new jabs from Pfizer and Moderna reached Americans.
Public health officials see Novavax's vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna, which teach cells how to make proteins that trigger an immune response against Covid. Novavax's shot fends off the virus with protein-based technology, a decades-old method used in routine vaccinations against hepatitis B and shingles.
The rise is driven by newer strains of the virus that are gaining ground nationwide as XBB.1.5 gradually declines. That includes EG.5, or Eris, an omicron strain that accounted forA Novavax spokesperson said last month its new Covid vaccine generated a"broad immune response" against Eris and another fast-spreading strain called XBB.1.16.6 – both of which are descendants of omicron.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA authorizes Novavax's updated COVID shot By ReutersUS FDA authorizes Novavax's updated COVID shot
Read more »
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.
Read more »
FDA Authorizes Novavax’s Updated Covid VaccineThe shot has been updated to target a strain of the coronavirus that was circulating earlier this year.
Read more »
Novavax Stock Jumps After FDA Approves Updated Covid VaccineShares were up more than 10% on the news, which came more than three weeks after vaccines from Moderna and Pfizer.
Read more »
FDA authorizes updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and Moderna.
Read more »
Novavax updated COVID vaccine gets FDA approvalStock jumps 12% on regulatory approval of new shot
Read more »